ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,430 | -2,511 | -1,890 | -456 | -1,400 |
| Depreciation Amortization | 120 | 73 | 48 | 24 | 90 |
| Other Working Capital | 100 | -159 | -62 | -29 | -470 |
| Other Operating Activity | 10 | 0 | 0 | 0 | 0 |
| Operating Cash Flow | $-3,200 | $-2,596 | $-1,904 | $-461 | $-1,780 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -40 | -32 | -27 | -11 | -4 |
| Investing Cash Flow | $-40 | $-32 | $-27 | $-11 | $-4 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 500 | 500 | N/A | 0 | N/A |
| Common Stock Issued | 30 | 88 | 23 | 11 | N/A |
| Other Financing Activity | 50 | 0 | 0 | 0 | 4,220 |
| Financing Cash Flow | $580 | $588 | $23 | $11 | $4,220 |
| Beginning Cash Position | 5,270 | 5,275 | 5,275 | 5,275 | 2,840 |
| End Cash Position | 2,610 | 3,235 | 3,366 | 4,813 | 5,270 |
| Net Cash Flow | $-2,660 | $-2,040 | $-1,909 | $-462 | $2,430 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,200 | -2,596 | -1,904 | -461 | -1,780 |
| Capital Expenditure | -43 | -32 | -27 | -11 | N/A |
| Free Cash Flow | -3,243 | -2,628 | -1,932 | -473 | -1,780 |